Tinea Capitis Infection in Children Along with Tertiary Care Hospitals with Reference to in Vitro Antifungal Susceptibility Testing of Dermatophyte Isolate

Background
Fungal infection of scalp and hair is clinically known as Tinea capitis.1Tinea capitis is the most common dermatophytic infection of childhood2, especially in school going children.3 It is self limiting disease of children below 20 years of age and seldom beyond puberty.3Fungal infection of scalp and hair is superficial cutaneous mycotic infection. The causative agent of Tinea capitis varies with geography, social status and Time, 15 although the clinical appearance is variable.15, 18Late detection and lack of treatment of this disease can result in wide spread infection and in rare cases permanent alopecia. It presents with a variety of clinical picture and more or less depends upon type of dermatophyte involved. Fungal infection of scalp and hair has worldwide distribution. In India the superficial cutaneous mycotic infection is quite common because of the favorable climatic conditions such as high temperature and humidity. Ketaconazole, fluconazole and Griseofulvin seems to be promising therapies against Tinea capitis. The discoveries of azole derivative and allied group of antifungal drugs are having significant impact in managing dermatophytosis3. The present study suggests that every patient of Tinea capitis infection should be properly studied for mycological examination and should be treated accordingly. This study revealed that Ketaconazole, Fluconazole, and Griseofulvin were the most ideal antifungal drugs for the treatment of Tinea capitis fungal infection.